დასაწყისი · კატალოგი · პროფილი · ცხრილი
კვება BODY HANDBOOK
კვება · §286
Goji and Sea Buckthorn Berries
Two berries the supplement aisle treats as interchangeable superfoods are actually doing two unrelated, narrow, real things. Goji is the densest food source of zeaxanthin — the orange pigment that lives in the centre of your retina and keeps the macula from thinning with age. Sea buckthorn oil is the densest food source of palmitoleic acid, the fatty acid the lipid layer of your tear film and the lining of mucous membranes are partly built from. Neither will change your life. If you have age-related vision concern, dry eye, postmenopausal dryness, or stubbornly high cholesterol, one or the other is a legitimate, cheap, food-form lever; if not, the bottle on the shelf is paying for marketing. And there are two safety footguns the marketing buries: goji potentiates warfarin badly enough that case reports include emergency-department visits, and the same berry sets off anaphylaxis in peach-allergic readers.
Decide · Daily Evidence Emerging თავი კვება

The real claims are small and specific. About a quarter-cup of dried goji with breakfast measurably raises the protective pigment in your retina over three months; two grams a day of sea buckthorn pulp oil measurably calms dry-eye burning and postmenopausal mucosal dryness over the same window; both nudge cholesterol down a little in people whose cholesterol is already up. Effort is trivial. Cost is modest — pennies a day for goji, $20–40 a month for the oil. The catch worth reading: if you're on warfarin or you can't eat a peach, skip the goji entirely.

The two berries are unrelated plants doing unrelated jobs, and the only reason they share the shelf is that both got slotted into the "superfood" category twenty years ago. Once you know what each actually delivers, the rest of the entry follows.

Goji is a carotenoid bus. The small red berry contains the highest known dietary concentration of zeaxanthin — about half a milligram to a milligram per gram dry weight, shipped in a chemical form (the dipalmitate ester) that absorbs better than the loose zeaxanthin in supplement pills. Zeaxanthin and its sibling lutein concentrate in the centre of your retina in a layer called the macular pigment, where they soak up short-wavelength blue light before it reaches the rods and cones and mop up the free radicals that light damage produces. The thicker that pigment layer, the lower your odds of age-related macular degeneration — the thinning of the central retina that gradually erases your reading vision after sixty. Eating goji raises the zeaxanthin in your blood; over three months it raises the pigment in your retina (Li 2021).

Sea buckthorn pulp oil is a fatty-acid bus. The orange berry of the Eurasian shrub Hippophae rhamnoides yields two oils with completely different compositions. The oil pressed from the fleshy pulp is dominated by palmitoleic acid, called omega-7 — it makes up a third to two-fifths of the fatty acids, more than any other common food. The oil pressed from the small seeds is roughly half omega-3 and half omega-6 instead. Palmitoleic acid happens to be the major fatty acid of human sebum and a building block of the lipid layer your tear film floats on and the membranes of your mucous-membrane cells. Swallow enough of it for a few months and the parts of you that depend on that lipid pool — the surface of your eye, the lining of the vagina after menopause, the outer layer of your skin — work a little better.

The honest-broker frame: goji is a food source of one specific carotenoid; sea buckthorn pulp oil is a food source of one specific fatty acid. The trial evidence backs each of those narrow claims. Everything else the bottle promises is marketing.

What the trials actually show

Three small randomised trials on goji and the eye. They line up.

The last result is the surprise — whole berries beating the targeted pill. The likely explanation is matrix effects: goji ships its zeaxanthin alongside fat, polysaccharides, and other carotenoids that may help absorption. The trials are all small, and one was unmasked, so the headline is "a real signal worth taking seriously," not "settled." No one has yet run the trial that would settle it: thousands of mid-life adults, dried goji versus pill versus placebo, AMD progression as the endpoint, ten years.

Two trials for sea buckthorn oil and dry eye, both from the same Finnish research group. One hundred adults with dry-eye symptoms — half of them contact-lens wearers — took 2 grams a day of pulp + seed oil or placebo for three months across a Finnish winter. The active arm's tear-film osmolarity — the saltiness that climbs as your tears evaporate too fast — rose less than the placebo arm's during the cold-season window, and self-reported burning and redness improved (Larmo 2010). A follow-up trial of pulp oil at the same dose for twelve weeks replicated the tear-film and symptom improvements (Yang 2023). The signal is small in absolute terms and the whole evidence base for sea buckthorn comes out of one university cluster — an honest caveat to weigh against a clean, replicable, mechanism-coherent result.

One trial for sea buckthorn oil and postmenopausal mucosal dryness. Ninety-eight women who had finished menopause and reported vaginal dryness, itching, or burning took 3 grams a day of pulp + seed oil or placebo for three months. Epithelial integrity of the vaginal lining, as assessed by their gynaecologist, was better in the active arm (Larmo 2014). The effect doesn't match a topical oestrogen — but for women whose breast-cancer history or other reasons take topical oestrogen off the table, the relevant comparison is "nothing," and against nothing this is a real option.

The same Finnish 12-week trial picked up an instrument-measured skin signal. Hydration, water loss through the outer layer, and skin elasticity all improved a little in the active arm (Yang 2023). An earlier small trial in atopic dermatitis (eczema) had found that pulp oil — but not seed oil — reduced symptom scores, suggesting the palmitoleic acid is the working ingredient and the effect runs through the same skin-barrier-lipid mechanism as the dry-eye signal (Yang 1999). None of this is cosmetic-procedure tier — nobody is changing what they look like from a bottle of berry oil in twelve weeks — but the skin slowly becomes a little more hydrated and a little less leaky, which over months and years is a real piece of the aging trajectory.

Eleven randomised trials of sea buckthorn (berry, oil, or extract) and blood lipids, pooled in a meta-analysis. Average effect on LDL cholesterol of about a 12-point drop, with similar small improvements in HDL and triglycerides. The catch: the effect was confined to people whose lipids were already abnormal. Healthy adults with normal cholesterol show no change in either direction (Guo 2017). A later meta-analysis with fifteen trials reached the same conclusion (Hou 2022). Sub-statin in size, useful as a piece of a broader lifestyle change in someone whose cholesterol is creeping up; pointless in someone whose cholesterol is fine.

How much, in what form, for what

The doses below are the ones the trials actually used. Above them you don't get more; below them the signal disappears into noise.

If you're using the berries for the lipid effect, eight to twelve weeks is the right window to see the change in a follow-up blood panel. Goji and sea buckthorn together aren't synergistic — they're doing unrelated jobs — so there's no reason to take both unless you have indications for both.

Frozen sea buckthorn pulp and juice are common in northern and central Europe and considerably cheaper per gram of palmitoleic acid than capsules; if you can find them, they work. Sea buckthorn juice is tart almost past usability straight — blends with apple or pear juice are how it's normally consumed.

Who should skip goji entirely

Two groups. The marketing buries both.

Sea buckthorn has no documented warfarin-interaction case reports, but it carries the same general flavonoid load as other dark berries that mildly thin blood; if you're on a blood thinner, ask the clinician managing your anticoagulation before adding a high-dose oil. Allergy to sea buckthorn exists but is rare.

One harmless cosmetic side note: very high carotenoid intake — eating goji at far above the studied dose for months — can tint your palms and soles slightly yellow-orange (carotenoderma). It's reversible and bothers no one but the person noticing it in the mirror.

What the marketing gets wrong

  • "Antioxidant superfood" is the wrong frame for either berry. The trials don't support a vague whole-body antioxidant or anti-ageing claim. They support a narrow carotenoid-delivery effect for goji and a narrow fatty-acid-delivery effect for sea buckthorn. If you don't have an indication for the carotenoid (no AMD risk, no eye concern) or the fatty acid (no dry eye, no postmenopausal dryness, no high cholesterol), there's nothing for the food to do that your regular diet isn't doing already.
  • Goji is not "good for everyone." Two large groups — anyone on warfarin and anyone peach-allergic — should categorically avoid it.
  • Sea buckthorn omega-7 is not a fish-oil-equivalent cholesterol drug. The lipid effect, when it shows up, comes from the whole-berry mix of flavonoids and phytosterols, not from palmitoleic acid as such. And it only shows up in people whose cholesterol is already abnormal. Marketing the omega-7 angle as a heart-disease intervention overstates what the data say.
  • AMD prevention is not "established." No trial has tracked goji eaters over five or ten years and counted AMD diagnoses; what we have is a three-month surrogate marker (the pigment density itself) moving in the right direction. The underlying carotenoid–AMD relationship is solid from the AREDS2 supplement trial at higher doses, which is the strongest reason to take the goji signal seriously — but a confident "eat goji and you won't get AMD" sentence is over-claiming.
  • "Juice is concentrated nutrition." Most Western "goji juice" products are diluted blends sweetened with apple or grape juice; gram for gram of zeaxanthin they cost many times what dried berries do. Read the label; if zeaxanthin per serving isn't listed, you're paying for marketing.

Who actually benefits

The honest list is short.

  • You're over 45, screen-heavy, or have AMD in your family. Goji is a legitimate food source of the pigment that protects the macula. Eat the berries. Skip if you're on warfarin or peach-allergic.
  • You have dry eye — especially the evaporative kind that flares in winter or when wearing contacts. Sea buckthorn pulp oil at two grams a day for three months is one of the few oral interventions with a clean trial signal. Try it before more expensive prescription options if the symptoms are mild to moderate.
  • You're postmenopausal with vaginal dryness and topical oestrogen is off the table — because of a breast-cancer history, your own preference, or a clinician's caution. Three grams a day of pulp + seed oil is a non-hormonal option that improved mucosal integrity in the trial.
  • Your cholesterol is creeping up and you're stacking lifestyle levers before considering a statin. Sea buckthorn berry or oil is one small piece of that stack; expect a few-point drop in LDL, not a transformation. If your cholesterol is already in range, skip.

If none of those describes you, neither berry is going to do anything for you that your normal diet isn't already doing. Save the money.

Where to buy and what it costs

Dried goji are widely available in supermarkets, health-food stores, and — usually cheapest — Chinese groceries, where they're sold as gouqizi in bulk bags. A pound of dried berries runs ten to twenty-five dollars depending on source and certification; at the studied dose, that's pennies a day. Two flags worth knowing: heavy-metal contamination has been an issue in past batches of Chinese-origin goji, so a certified-organic European product costs more but trades that cost for batch testing; and dried berries vary in zeaxanthin content with how long they were dried and at what temperature. There's no easy way to test for it at the consumer end, so cycle through a couple of brands and pick the one you like.

Sea buckthorn oil is harder to find. Capsules from supplement brands cost twenty to forty dollars a month at the studied dose; check the label for pulp oil specifically (or a pulp+seed blend) if dry eye is the indication, since seed-oil-only products carry the omega-3 but not the omega-7. Refrigerate after opening — the oil oxidises faster than dried fruit. Liquid pulp oil from a glass bottle is cheaper per gram than capsules but the taste is strong and finishing the bottle before it goes off matters.

If you live somewhere sea buckthorn grows wild — much of Scandinavia, the Baltics, Russia, parts of central Asia — frozen pulp and juice are far cheaper than capsules and just as effective per gram of palmitoleic acid. The juice is tart almost past usability straight; blend it with apple or pear juice or a smoothie.

A few adjacent topics worth knowing about:

  • Lutein and zeaxanthin supplements directly — the AREDS2 trial dose of 10 mg lutein + 2 mg zeaxanthin daily is the established intervention for slowing AMD progression in people already diagnosed with it. Goji is the food-form alternative; the pill is the clinical-trial-proven alternative.
  • Other rich sources of macular carotenoids — egg yolks, kale, spinach, corn. Goji is the densest gram-for-gram but a varied diet covers it.
  • Topical oestrogen for postmenopausal vaginal dryness — the first-line option for women without a contraindication; sea buckthorn oil is the second-line option for those who can't take it.
  • Statins and other lipid-lowering interventions — sea buckthorn's lipid effect is small; if your cholesterol is high enough to matter, the conversation with your clinician is about whether to start a statin, not whether to add a berry.
  • Omega-3 supplementation — for dry eye, EPA/DHA fish oil also has a trial signal; the omega-7 / sea buckthorn route is one option alongside it.
·
286